Drug reference

anthrax vaccine adsorbed

adsorbed vaccine · vaccine

adsorbed vaccinevaccine

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Anthrax vaccine adsorbed induces immunity against Bacillus anthracis, the bacterium causing anthrax, protecting against both cutaneous and inhalation forms of the disease.

Indications

prevention of cutaneous and inhalation anthrax acquired by exposure on skin or by inhalation, for certain at-risk adults (18 to 65 years of age), including some U.S. military members, laboratory workers, veterinarians, or individuals handling animals or animal products

Dosing

Adult: given as multiple booster injections. CDC recommends intramuscular booster shots at 1, 6, 12, and 18 months, and then annually.

Related guidelines

Community-acquired pneumonia

ICMR · Pulmonology · 2022

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Tobacco-related cancer prevention

ICMR · Oncology · 2021

Cardiovascular disease prevention

ESC · Cardiology · 2021

Primary prevention of cardiovascular disease

AHA · Cardiology · 2019

Ask House about anthrax vaccine adsorbed

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team